Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future (Q38680756)

5 September 2017

1 reference

title

Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future (English)

1 reference

5 September 2017

0 references

cardiovascular disease

1 reference

Yasuhiro Watanabe

1

1 reference

PubMed ID

28531360

5 September 2017

Ichiro Tatsuno

series ordinal

2

1 reference

PubMed ID

28531360

5 September 2017

language of work or name

English

0 references

publication date

20 May 2017

1 reference

Expert Review of Clinical Pharmacology

5 September 2017

1 reference

5 September 2017

10

1 reference

5 September 2017

8

1 reference

5 September 2017

865-873

1 reference

Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006.

5 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Incorporation and washout of n-3 polyunsaturated fatty acids after diet supplementation in clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Triglycerides and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Why do omega-3 fatty acids lower serum triglycerides?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effect of TAK-085 on Low-density Lipoprotein Particle Size in Patients with Hypertriglyceridemia: A Double-blind Randomized Clinical Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Increasing long-chain n-3PUFA consumption improves small peripheral artery function in patients at intermediate-high cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Intakes of omega-3 polyunsaturated fatty acids and blood pressure change over time: Possible interaction with genes involved in 20-HETE and EETs metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

High long-chain n-3 fatty acid intake attenuates the effect of high resting heart rate on cardiovascular mortality risk: a 24-year follow-up of Japanese general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Fish intake, contaminants, and human health: evaluating the risks and the benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Genetic and pharmacological inhibition of the 5-lipoxygenase/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Does Omega-3 supplementation decrease carotid intima-media thickening in hemodialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Long-chain n-3 polyunsaturated fatty acids intake and cardiovascular disease mortality risk in Japanese: a 24-year follow-up of NIPPON DATA80.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

n-3 fatty acids and cardiovascular events after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

n-3 fatty acids in patients with multiple cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Fish Consumption, Omega-3 Fatty Acids, and Risk of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Omega-3 Fatty Acid Therapy: The Tide Turns for a Fish Story.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Omega-6 and omega-3 polyunsaturated fatty acid levels are reduced in whole blood of Italian patients with a recent myocardial infarction: the AGE-IM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

The association between dietary omega-3 fatty acids and cardiovascular death: the Singapore Chinese Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

A rapid method for determining arachidonic:eicosapentaenoic acid ratios in whole blood lipids: correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Fish intake and risk of incident heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Fish intake and the risk of incident heart failure: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Fish intake and risk of incident atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Fish oil and post-operative atrial fibrillation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Pro-resolving lipid mediators are leads for resolution physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Resolvin E1 protects the rat heart against reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Is the Effect of Omega-3 Polyunsaturated Fatty Acids Dependent on Life-Style, Severity of Disease, and Use of Concomitant Medications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17512433.2017.1333902

10.1080/17512433.2017.1333902

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

28531360